Article
Preclinical Assessment of Synergistic Efficacy of MELK and CDKs inhibitors in Adrenocortical Cancer
2022-05-16
Abstract excerpt
<title>Abstract</title> <p>Background Adrenocortical cancer (ACC) is a rare and aggressive cancer with dismal 5-year survival due to a lack of effective treatments. We aimed to identify a new effective combination of drugs and investigated their synergistic efficacy in ACC preclinical models. Methods A quantitative high-throughput drug screening of 4,991 compounds was performed on two ACC cell lines, SW13 and N...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cf015cc5-2e84-51e4-8ebb-84c20f6093ba
- DOI
- 10.21203/rs.3.rs-1631195/v1
